isomethyleugenol has been researched along with Nerve Sheath Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadi, R; Arp, M; Becker, A; Bewerunge-Hudler, M; Capper, D; Hänggi, D; Hartmann, C; Heim, S; Herold-Mende, C; Hovestadt, V; Jones, DT; Koelsche, C; Kratz, A; Mautner, VF; Mawrin, C; Mechtersheimer, G; Mittelbronn, M; Okuducu, AF; Paulus, W; Perry, A; Pfister, SM; Reuss, DE; Reuss, J; Röhrich, M; Sahm, F; Schittenhelm, J; Schrimpf, D; Seiz-Rosenhagen, M; Unterberg, A; von Deimling, A; Weis, J | 1 |
| Nakagawa, H; Nobeyama, Y | 1 |
2 other study(ies) available for isomethyleugenol and Nerve Sheath Neoplasms
| Article | Year |
|---|---|
Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
Topics: Humans; Methylation; Nerve Sheath Neoplasms; Neurilemmoma; Neurofibromatoses; Neurofibromin 1; Sarcoma; Skin Neoplasms | 2016 |
MAGEA3 methylation status is associated with prognosis of malignant peripheral nerve sheath tumor and with neurofibroma type in neurofibromatosis type 1.
Topics: Antigens, Neoplasm; CpG Islands; DNA Methylation; Humans; Kaplan-Meier Estimate; Methylation; Neoplasm Proteins; Nerve Sheath Neoplasms; Neurofibroma; Neurofibromatosis 1; Prognosis; RNA, Messenger; Treatment Outcome | 2016 |